Masimo Corporation (NASDAQ:MASI) Receives $181.17 Consensus PT from Analysts

Shares of Masimo Corporation (NASDAQ:MASI) have earned an average recommendation of “Reduce” from the nine research firms that are currently covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation and eight have issued a hold recommendation on the company. The average 12 month target price among analysts that have updated their coverage on the stock in the last year is $181.1667.

Several analysts have weighed in on the company. Weiss Ratings reiterated a “sell (d)” rating on shares of Masimo in a research note on Thursday, January 22nd. Piper Sandler downgraded shares of Masimo from an “overweight” rating to a “hold” rating and set a $180.00 price objective for the company. in a research report on Tuesday, February 17th. Raymond James Financial downgraded Masimo from an “outperform” rating to a “market perform” rating in a research note on Friday, March 27th. BTIG Research lowered shares of Masimo from a “buy” rating to a “neutral” rating in a research note on Wednesday, February 18th. Finally, Wells Fargo & Company upgraded Masimo to a “hold” rating in a report on Wednesday, March 18th.

Masimo Stock Up 0.1%

MASI stock opened at $178.71 on Tuesday. The stock has a market capitalization of $9.60 billion, a PE ratio of -16.96, a price-to-earnings-growth ratio of 1.81 and a beta of 1.20. The company has a quick ratio of 1.47, a current ratio of 2.49 and a debt-to-equity ratio of 0.72. Masimo has a 52 week low of $125.94 and a 52 week high of $179.00. The firm has a 50 day moving average of $175.08 and a 200 day moving average of $152.88.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of MASI. Global Retirement Partners LLC acquired a new stake in Masimo during the fourth quarter worth about $27,000. Aster Capital Management DIFC Ltd acquired a new position in Masimo in the 4th quarter valued at about $28,000. Los Angeles Capital Management LLC acquired a new position in Masimo in the 4th quarter valued at about $31,000. Rothschild Investment LLC grew its stake in shares of Masimo by 12,950.0% in the 4th quarter. Rothschild Investment LLC now owns 261 shares of the medical equipment provider’s stock valued at $34,000 after buying an additional 259 shares during the period. Finally, Torren Management LLC acquired a new stake in shares of Masimo during the 4th quarter worth approximately $35,000. Institutional investors and hedge funds own 85.96% of the company’s stock.

About Masimo

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.